遠方信息(300306.SZ):“遠方長益 2 號”員工持股計劃存續期延期一年
格隆匯3月13日丨遠方信息(300306.SZ)公佈,“遠方長益2號”員工持股計劃的存續期不超過36個月,自管理委員會購入公司股票之日起計算,即為2017年5月17日至2020年5月16日。該員工持股計劃目前持有公司流通股56.01萬股。
2020年3月5日“遠方長益2號”召開了持有人會議,經出席持有人會議的持有人所持2/3以上份額同意,通過了《關於“遠方長益2號”員工持股計劃延期的議案》,同意向公司董事會申請該員工持股計劃存續期延期一年,即存續期延長至2021年5月16日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.